公司简介

Synthego is a provider of synthetic RNA solutions for CRISPR Genome Engineering.

主要成员

Ted Tisch、Paul Dabrowski、Kevin Holden、Michael Dabrowski

产品/服务

• 基因合成/编辑

CRISPRevolution Synthetic sgRNA Kit	Achieve up to 97% editing efficiency with the highest quality synthetic sgRNA in the market.
Gene Knockout Kit	Guaranteed 50% or Greater Editing in Any Human Cell Line.
Whole Genome Synthetic sgRNA Libraries	CRISPR Screening for Comprehensive Target Identification in Human Cell Lines.

融资信息

融资轮次	融资日期	投资方	融资额度
Debt Financing	2012-08	未披露	$250K
Series A	2013-07	Menlo Ventures、Founders Fund、WI Harper Group	$8.3M
Series B	2017-01	Menlo Ventures、Founders Fund、ZhenFund、AME Cloud Ventures、WI Harper Group、8VC、Arab Angel Fund	$41M
C轮	2018-10	Founders Fund、Menlo Ventures、8VC	$110M
D轮	2020-08	RA Capital Management和8VC领投，Founders Fund，Menlo Ventures和Intel Capital参与投资	1亿美元

关联公司